Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 135

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 135
---
 options issued during the nine month periods ended September
30, 2025 and 2024 were as follows:

 Schedule of Grant Date Fair Value of Stock Options Issued

    September
    30,  
    September
    30, 

    2025  
    2024 
  
    Dividend
    Yield 
     0% 
     0%
  
    Weighted
    average expected term (years) 
     5.38-6.00  
     5.75-6 
  
    Volatility 
     65.68-101.98% 
     97.3-105.8%
  
    Risk-free
    rate 
     3.86-4.18% 
     4.10%
  
    Weighted
    average exercise price 
    $0.97  
    $1.33 

    17

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note
6 – Stockholders’ Equity, continued

A
summary of stock option activity for the nine months ended September 30, 2025 is presented below:

 Schedule of Stock Option Activity

    Number
    of Options  
    Weighted
    Average Exercise Price  
    Weighted
    Average Contractual Term (Years)  
    Aggregate
    Intrinsic Value 
  
    Outstanding
    as of December 31, 2024 
     10,633,988  
     1.02  
     6.25  
    $102,921,147 
  
    Granted 
     1,092,105  
     1.16  

    Exercised 
     -  
     -  

    Forfeited 
     -  
     -  

    Outstanding
    as of September 30, 2025 
     11,726,093  
    $1.03  
     5.68  
    $8,533,901 
  
    Exercisable
    as of September 30, 2025 
     10,814,635  
    $1.02  
     5.33  
    $7,994,141 

The
following table summarizes information related to stock options outstanding as of September 30, 202